Role of microRNA-mediated MMP regulation in the treatment and diagnosis of malignant tumors

References

• Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res 2003; 92:827 - 39; http://dx.doi.org/10.1161/01.RES.0000070112.80711.3D; PMID: 12730128
   PubMed Web of Science ®Google Scholar
• Murphy G, Nagase H. Progress in matrix metalloproteinase research. Mol Aspects Med 2008; 29:290 - 308; http://dx.doi.org/10.1016/j.mam.2008.05.002; PMID: 18619669
   PubMed Web of Science ®Google Scholar
• Gomis-Rüth FX. Catalytic domain architecture of metzincin metalloproteases. J Biol Chem 2009; 284:15353 - 7; http://dx.doi.org/10.1074/jbc.R800069200; PMID: 19201757
   PubMed Web of Science ®Google Scholar
• Curran S, Murray GI. Matrix metalloproteinases: molecular aspects of their roles in tumour invasion and metastasis. Eur J Cancer 2000; 36:13 Spec No 1621 - 30; http://dx.doi.org/10.1016/S0959-8049(00)00156-8; PMID: 10959048
   PubMed Web of Science ®Google Scholar
• Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2002; 2:161 - 74; http://dx.doi.org/10.1038/nrc745; PMID: 11990853
   PubMed Web of Science ®Google Scholar
• López-Otín C, Matrisian LM. Emerging roles of proteases in tumour suppression. Nat Rev Cancer 2007; 7:800 - 8; http://dx.doi.org/10.1038/nrc2228; PMID: 17851543
   PubMed Web of Science ®Google Scholar
• Ra HJ, Parks WC. Control of matrix metalloproteinase catalytic activity. Matrix Biol 2007; 26:587 - 96; http://dx.doi.org/10.1016/j.matbio.2007.07.001; PMID: 17669641
   PubMed Web of Science ®Google Scholar
• Clark IM, Swingler TE, Sampieri CL, Edwards DR. The regulation of matrix metalloproteinases and their inhibitors. Int J Biochem Cell Biol 2008; 40:1362 - 78; http://dx.doi.org/10.1016/j.biocel.2007.12.006; PMID: 18258475
   PubMed Web of Science ®Google Scholar
• Mannello F, Medda V. Nuclear localization of matrix metalloproteinases. Prog Histochem Cytochem 2012; 47:27 - 58; http://dx.doi.org/10.1016/j.proghi.2011.12.002; PMID: 22226510
   PubMed Web of Science ®Google Scholar
• Sbardella D, Fasciglione GF, Gioia M, Ciaccio C, Tundo GR, Marini S, et al. Human matrix metalloproteinases: an ubiquitarian class of enzymes involved in several pathological processes. Mol Aspects Med 2012; 33:119 - 208; http://dx.doi.org/10.1016/j.mam.2011.10.015; PMID: 22100792
   PubMed Web of Science ®Google Scholar
• Chaudhary A, Pandya S, Ghosh K, Nadkarni A. Matrix metalloproteinase and its drug targets therapy in solid and hematological malignancies: An overview. Mutat Res Rev Mutat Res 2013; http://dx.doi.org/10.1016/j.mrrev.2013.01.002
   PubMed Web of Science ®Google Scholar
• Hubmacher D, Apte SS. The biology of the extracellular matrix: novel insights. Curr Opin Rheumatol 2013; 25:65 - 70; http://dx.doi.org/10.1097/BOR.0b013e32835b137b; PMID: 23143224
   PubMed Web of Science ®Google Scholar
• Murphy G. Tissue inhibitors of metalloproteinases. Genome Biol 2011; 12:233; http://dx.doi.org/10.1186/gb-2011-12-11-233; PMID: 22078297
   PubMed Web of Science ®Google Scholar
• Dalmay T, Edwards DR. MicroRNAs and the hallmarks of cancer. Oncogene 2006; 25:6170 - 5; http://dx.doi.org/10.1038/sj.onc.1209911; PMID: 17028596
   PubMed Web of Science ®Google Scholar
• Croce CM. Oncogenes and cancer. N Engl J Med 2008; 358:502 - 11; http://dx.doi.org/10.1056/NEJMra072367; PMID: 18234754
   PubMed Web of Science ®Google Scholar
• Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer 2006; 6:259 - 69; http://dx.doi.org/10.1038/nrc1840; PMID: 16557279
   PubMed Web of Science ®Google Scholar
• He L, He X, Lowe SW, Hannon GJ. microRNAs join the p53 network--another piece in the tumour-suppression puzzle. Nat Rev Cancer 2007; 7:819 - 22; http://dx.doi.org/10.1038/nrc2232; PMID: 17914404
   PubMed Web of Science ®Google Scholar
• Kent OA, Mendell JT. A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes. Oncogene 2006; 25:6188 - 96; http://dx.doi.org/10.1038/sj.onc.1209913; PMID: 17028598
   PubMed Web of Science ®Google Scholar
• Osaki M, Takeshita F, Ochiya T. MicroRNAs as biomarkers and therapeutic drugs in human cancer. Biomarkers 2008; 13:658 - 70; http://dx.doi.org/10.1080/13547500802646572; PMID: 19096960
   PubMed Web of Science ®Google Scholar
• Fanjul-Fernández M, Folgueras AR, Cabrera S, López-Otín C. Matrix metalloproteinases: evolution, gene regulation and functional analysis in mouse models. Biochim Biophys Acta 2010; 1803:3 - 19; http://dx.doi.org/10.1016/j.bbamcr.2009.07.004; PMID: 19631700
   PubMed Web of Science ®Google Scholar
• Piperi C, Papavassiliou AG. Molecular mechanisms regulating matrix metalloproteinases. Curr Top Med Chem 2012; 12:1095 - 112; http://dx.doi.org/10.2174/1568026611208011095; PMID: 22519442
   PubMed Web of Science ®Google Scholar
• Overall CM. Molecular determinants of metalloproteinase substrate specificity: matrix metalloproteinase substrate binding domains, modules, and exosites. Mol Biotechnol 2002; 22:51 - 86; http://dx.doi.org/10.1385/MB:22:1:051; PMID: 12353914
   PubMed Web of Science ®Google Scholar
• Huang L, Dai T, Lin X, Zhao X, Chen X, Wang C, et al. MicroRNA-224 targets RKIP to control cell invasion and expression of metastasis genes in human breast cancer cells. Biochem Biophys Res Commun 2012; 425:127 - 33; http://dx.doi.org/10.1016/j.bbrc.2012.07.025; PMID: 22809510
   PubMed Web of Science ®Google Scholar
• Hwang SJ, Seol HJ, Park YM, Kim KH, Gorospe M, Nam DH, et al. MicroRNA-146a suppresses metastatic activity in brain metastasis. Mol Cells 2012; 34:329 - 34; http://dx.doi.org/10.1007/s10059-012-0171-6; PMID: 22949171
   PubMed Web of Science ®Google Scholar
• Wu J, Wu G, Lv L, Ren YF, Zhang XJ, Xue YF, et al. MicroRNA-34a inhibits migration and invasion of colon cancer cells via targeting to Fra-1. Carcinogenesis 2012; 33:519 - 28; http://dx.doi.org/10.1093/carcin/bgr304; PMID: 22198213
   PubMed Web of Science ®Google Scholar
• Liu X, Yu J, Jiang L, Wang A, Shi F, Ye H, et al. MicroRNA-222 regulates cell invasion by targeting matrix metalloproteinase 1 (MMP1) and manganese superoxide dismutase 2 (SOD2) in tongue squamous cell carcinoma cell lines. Cancer Genomics Proteomics 2009; 6:131 - 9; PMID: 19487542
   PubMedGoogle Scholar
• Xu N, Zhang L, Meisgen F, Harada M, Heilborn J, Homey B, et al. MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion. J Biol Chem 2012; 287:29899 - 908; http://dx.doi.org/10.1074/jbc.M112.391243; PMID: 22782903
   PubMed Web of Science ®Google Scholar
• Chang HJ, Yang MJ, Yang YH, Hou MF, Hsueh EJ, Lin SR. MMP13 is potentially a new tumor marker for breast cancer diagnosis. Oncol Rep 2009; 22:1119 - 27; PMID: 19787229
   PubMed Web of Science ®Google Scholar
• Impola U, Uitto VJ, Hietanen J, Hakkinen L, Zhang L, Larjava H, et al. Differential expression of matrilysin-1 (MMP-7), 92 kD gelatinase (MMP-9), and metalloelastase (MMP-12) in oral verrucous and squamous cell cancer. J Pathol 2004; 202:14 - 22; http://dx.doi.org/10.1002/path.1479; PMID: 14694517
   PubMed Web of Science ®Google Scholar
• Boström PJ, Ravanti L, Reunanen N, Aaltonen V, Söderström KO, Kähäri VM, et al. Expression of collagenase-3 (matrix metalloproteinase-13) in transitional-cell carcinoma of the urinary bladder. Int J Cancer 2000; 88:417 - 23; http://dx.doi.org/10.1002/1097-0215(20001101)88:3<417::AID-IJC14>3.0.CO;2-G; PMID: 11054671
   PubMed Web of Science ®Google Scholar
• Osaki M, Takeshita F, Sugimoto Y, Kosaka N, Yamamoto Y, Yoshioka Y, et al. MicroRNA-143 regulates human osteosarcoma metastasis by regulating matrix metalloprotease-13 expression. Mol Ther 2011; 19:1123 - 30; http://dx.doi.org/10.1038/mt.2011.53; PMID: 21427707
   PubMed Web of Science ®Google Scholar
• Moilanen M, Pirilä E, Grénman R, Sorsa T, Salo T. Expression and regulation of collagenase-2 (MMP-8) in head and neck squamous cell carcinomas. J Pathol 2002; 197:72 - 81; http://dx.doi.org/10.1002/path.1078; PMID: 12081207
   PubMed Web of Science ®Google Scholar
• Stadlmann S, Pollheimer J, Moser PL, Raggi A, Amberger A, Margreiter R, et al. Cytokine-regulated expression of collagenase-2 (MMP-8) is involved in the progression of ovarian cancer. Eur J Cancer 2003; 39:2499 - 505; http://dx.doi.org/10.1016/j.ejca.2003.08.011; PMID: 14602136
   PubMed Web of Science ®Google Scholar
• Balbín M, Fueyo A, Tester AM, Pendás AM, Pitiot AS, Astudillo A, et al. Loss of collagenase-2 confers increased skin tumor susceptibility to male mice. Nat Genet 2003; 35:252 - 7; http://dx.doi.org/10.1038/ng1249; PMID: 14517555
   PubMed Web of Science ®Google Scholar
• Gearing AJ, Beckett P, Christodoulou M, Churchill M, Clements J, Davidson AH, et al. Processing of tumour necrosis factoralpha precursor by metalloproteinases. Nature 1994; 6490:555 - 7; http://dx.doi.org/10.1038/370555a0
   Web of Science ®Google Scholar
• Zheng X, Chopp M, Lu Y, Buller B, Jiang F. MiR-15b and miR-152 reduce glioma cell invasion and angiogenesis via NRP-2 and MMP-3. Cancer Lett 2013; 329:146 - 54; http://dx.doi.org/10.1016/j.canlet.2012.10.026; PMID: 23142217
   PubMed Web of Science ®Google Scholar
• Graff JW, Powers LS, Dickson AM, Kim J, Reisetter AC, Hassan IH, et al. Cigarette smoking decreases global microRNA expression in human alveolar macrophages. PLoS One 2012; 7:e44066; http://dx.doi.org/10.1371/journal.pone.0044066; PMID: 22952876
   PubMed Web of Science ®Google Scholar
• Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev 2000; 14:163 - 76; PMID: 10652271
   PubMed Web of Science ®Google Scholar
• McQuibban GA, Gong JH, Wong JP, Wallace JL, Clark-Lewis I, Overall CM. Matrix metalloproteinase processing of monocyte chemoattractant proteins generates CC chemokine receptor antagonists with anti-inflammatory properties in vivo. Blood 2002; 100:1160 - 7; PMID: 12149192
   PubMed Web of Science ®Google Scholar
• Han L, Zhang A, Zhou X, Xu P, Wang GX, Pu PY, et al. Downregulation of Dicer enhances tumor cell proliferation and invasion. Int J Oncol 2010; 37:299 - 305; PMID: 20596657
   PubMed Web of Science ®Google Scholar
• Shi L, Wan Y, Sun G, Gu X, Qian C, Yan W, et al. Functional differences of miR-125b on the invasion of primary glioblastoma CD133-negative cells and CD133-positive cells. Neuromolecular Med 2012; 14:303 - 16; http://dx.doi.org/10.1007/s12017-012-8188-8; PMID: 22711523
   PubMed Web of Science ®Google Scholar
• Alpini G, Glaser SS, Zhang JP, Francis H, Han Y, Gong J, et al. Regulation of placenta growth factor by microRNA-125b in hepatocellular cancer. J Hepatol 2011; 55:1339 - 45; http://dx.doi.org/10.1016/j.jhep.2011.04.015; PMID: 21703189
   PubMed Web of Science ®Google Scholar
• Zhu Q, Wang Z, Hu Y, Li J, Li X, Zhou L, et al. miR-21 promotes migration and invasion by the miR-21-PDCD4-AP-1 feedback loop in human hepatocellular carcinoma. Oncol Rep 2012; 27:1660 - 8; PMID: 22322403
   PubMed Web of Science ®Google Scholar
• Giovannetti E, Funel N, Peters GJ, Del Chiaro M, Erozenci LA, Vasile E, et al. MicroRNA-21 in pancreatic cancer: correlation with clinical outcome and pharmacologic aspects underlying its role in the modulation of gemcitabine activity. Cancer Res 2010; 70:4528 - 38; http://dx.doi.org/10.1158/0008-5472.CAN-09-4467; PMID: 20460539
   PubMed Web of Science ®Google Scholar
• Hu Y, Ou Y, Wu K, Chen Y, Sun W. miR-143 inhibits the metastasis of pancreatic cancer and an associated signaling pathway. Tumour Biol 2012; 33:1863 - 70; http://dx.doi.org/10.1007/s13277-012-0446-8; PMID: 23070684
   PubMed Web of Science ®Google Scholar
• Nan Y, Han L, Zhang A, Wang G, Jia Z, Yang Y, et al. MiRNA-451 plays a role as tumor suppressor in human glioma cells. Brain Res 2010; 1359:14 - 21; http://dx.doi.org/10.1016/j.brainres.2010.08.074; PMID: 20816946
   PubMed Web of Science ®Google Scholar
• Wu DG, Wang YY, Fan LG, Luo H, Han B, Sun LH, et al. MicroRNA-7 regulates glioblastoma cell invasion via targeting focal adhesion kinase expression. Chin Med J (Engl) 2011; 124:2616 - 21; PMID: 22040413
   PubMed Web of Science ®Google Scholar
• Liu H, Cao YD, Ye WX, Sun YY. Effect of microRNA-206 on cytoskeleton remodelling by downregulating Cdc42 in MDA-MB-231 cells. Tumori 2010; 96:751 - 5; PMID: 21302623
   PubMed Web of Science ®Google Scholar
• Wu ZS, Wu Q, Wang CQ, Wang XN, Huang J, Zhao JJ, et al. miR-340 inhibition of breast cancer cell migration and invasion through targeting of oncoprotein c-Met. Cancer 2011; 117:2842 - 52; http://dx.doi.org/10.1002/cncr.25860; PMID: 21692045
   PubMed Web of Science ®Google Scholar
• Liu N, Sun Q, Chen J, Li J, Zeng Y, Zhai S, et al. MicroRNA-9 suppresses uveal melanoma cell migration and invasion through the NF-κB1 pathway. Oncol Rep 2012; 28:961 - 8; PMID: 22825752
   PubMed Web of Science ®Google Scholar
• Liao YL, Hu LY, Tsai KW, Wu CW, Chan WC, Li SC, et al. Transcriptional regulation of miR-196b by ETS2 in gastric cancer cells. Carcinogenesis 2012; 33:760 - 9; http://dx.doi.org/10.1093/carcin/bgs023; PMID: 22298639
   PubMed Web of Science ®Google Scholar
• Steele R, Mott JL, Ray RB. MBP-1 upregulates miR-29b that represses Mcl-1, collagens, and matrix-metalloproteinase-2 in prostate cancer cells. Genes Cancer 2010; 1:381 - 7; http://dx.doi.org/10.1177/1947601910371978; PMID: 20657750
   PubMedGoogle Scholar
• Fang JH, Zhou HC, Zeng C, Yang J, Liu Y, Huang X, et al. MicroRNA-29b suppresses tumor angiogenesis, invasion, and metastasis by regulating matrix metalloproteinase 2 expression. Hepatology 2011; 54:1729 - 40; http://dx.doi.org/10.1002/hep.24577; PMID: 21793034
   PubMed Web of Science ®Google Scholar
• Ding Q, Chang CJ, Xie X, Xia W, Yang JY, Wang SC, et al. APOBEC3G promotes liver metastasis in an orthotopic mouse model of colorectal cancer and predicts human hepatic metastasis. J Clin Invest 2011; 121:4526 - 36; http://dx.doi.org/10.1172/JCI45008; PMID: 21985787
   PubMed Web of Science ®Google Scholar
• Dong CG, Wu WK, Feng SY, Wang XJ, Shao JF, Qiao J. Co-inhibition of microRNA-10b and microRNA-21 exerts synergistic inhibition on the proliferation and invasion of human glioma cells. Int J Oncol 2012; 41:1005 - 12; PMID: 22766763
   PubMed Web of Science ®Google Scholar
• Ren J, Sun Y, Zhao X, Wang X, Feng J, Liu M, et al. Downregulation of miR-21 regulates MMP-2 expression and suppress migration of Laryngeal squamous cell carcinoma. Head Neck Oncol 2012; 4:65; PMID: 23104547
   PubMedGoogle Scholar
• Shen K, Liang Q, Xu K, Cui D, Jiang L, Yin P, et al. MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor. Biochem Pharmacol 2012; 84:320 - 30; http://dx.doi.org/10.1016/j.bcp.2012.04.017; PMID: 22580051
   PubMed Web of Science ®Google Scholar
• Cho HM, Jeon HS, Lee SY, Jeong KJ, Park SY, Lee HY, et al. microRNA-101 inhibits lung cancer invasion through the regulation of enhancer of zeste homolog 2. Exp Ther Med 2011; 2:963 - 7; PMID: 22977606
   PubMed Web of Science ®Google Scholar
• Liu P, Wilson MJ. miR-520c and miR-373 upregulate MMP9 expression by targeting mTOR and SIRT1, and activate the Ras/Raf/MEK/Erk signaling pathway and NF-κB factor in human fibrosarcoma cells. J Cell Physiol 2012; 227:867 - 76; http://dx.doi.org/10.1002/jcp.22993; PMID: 21898400
   PubMed Web of Science ®Google Scholar
• Liu B, Wu X, Liu B, Wang C, Liu Y, Zhou Q, et al. MiR-26a enhances metastasis potential of lung cancer cells via AKT pathway by targeting PTEN. Biochim Biophys Acta 2012; 1822:1692 - 704; http://dx.doi.org/10.1016/j.bbadis.2012.07.019; PMID: 22885155
   PubMed Web of Science ®Google Scholar
• Yan W, Zhang W, Sun L, Liu Y, You G, Wang Y, et al. Identification of MMP-9 specific microRNA expression profile as potential targets of anti-invasion therapy in glioblastoma multiforme. Brain Res 2011; 1411:108 - 15; PMID: 21831363
   PubMed Web of Science ®Google Scholar
• Wan Y, Fei XF, Wang ZM, Jiang DY, Chen HC, Yang J, et al. Expression of miR-125b in the new, highly invasive glioma stem cell and progenitor cell line SU3. Chin J Cancer 2012; 31:207 - 14; http://dx.doi.org/10.5732/cjc.011.10336; PMID: 22360855
   PubMedGoogle Scholar
• Song L, Huang Q, Chen K, Liu L, Lin C, Dai T, et al. miR-218 inhibits the invasive ability of glioma cells by direct downregulation of IKK-β. Biochem Biophys Res Commun 2010; 402:135 - 40; http://dx.doi.org/10.1016/j.bbrc.2010.10.003; PMID: 20933503
   PubMed Web of Science ®Google Scholar
• Liu Y, Yan W, Zhang W, Chen L, You G, Bao Z, et al. MiR-218 reverses high invasiveness of glioblastoma cells by targeting the oncogenic transcription factor LEF1. Oncol Rep 2012; 28:1013 - 21; PMID: 22766851
   PubMed Web of Science ®Google Scholar
• Huang XH, Chen JS, Wang Q, Chen XL, Wen L, Chen LZ, et al. miR-338-3p suppresses invasion of liver cancer cell by targeting smoothened. J Pathol 2011; 225:463 - 72; http://dx.doi.org/10.1002/path.2877; PMID: 21671467
   PubMed Web of Science ®Google Scholar
• Li Q, Wang G, Shan JL, Yang ZX, Wang HZ, Feng J, et al. MicroRNA-224 is upregulated in HepG2 cells and involved in cellular migration and invasion. J Gastroenterol Hepatol 2010; 25:164 - 71; http://dx.doi.org/10.1111/j.1440-1746.2009.05971.x; PMID: 19793168
   PubMed Web of Science ®Google Scholar
• Gao P, Xing AY, Zhou GY, Zhang TG, Zhang JP, Gao C, et al. The molecular mechanism of microRNA-145 to suppress invasion-metastasis cascade in gastric cancer. Oncogene 2013; 32:491 - 501; http://dx.doi.org/10.1038/onc.2012.61; PMID: 22370644
   PubMed Web of Science ®Google Scholar
• Lohi J, Wilson CL, Roby JD, Parks WCE. Epilysin, a novel human matrix metalloproteinase (MMP-28) expressed in testis and keratinocytes and in response to injury. J Biol Chem 2001; 276:10134 - 44; http://dx.doi.org/10.1074/jbc.M001599200; PMID: 11121398
   PubMed Web of Science ®Google Scholar
• Velasco G, Pendás AM, Fueyo A, Knäuper V, Murphy G, López-Otín C. Cloning and characterization of human MMP-23, a new matrix metalloproteinase predominantly expressed in reproductive tissues and lacking conserved domains in other family members. J Biol Chem 1999; 274:4570 - 6; http://dx.doi.org/10.1074/jbc.274.8.4570; PMID: 9988691
   PubMed Web of Science ®Google Scholar
• Uchibori M, Nishida Y, Nagasaka T, Yamada Y, Nakanishi K, Ishiguro N. Increased expression of membrane-type matrix metalloproteinase-1 is correlated with poor prognosis in patients with osteosarcoma. Int J Oncol 2006; 28:33 - 42; PMID: 16327977
   PubMed Web of Science ®Google Scholar
• Ip YC, Cheung ST, Fan ST. Atypical localization of membrane type 1-matrix metalloproteinase in the nucleus is associated with aggressive features of hepatocellular carcinoma. Mol Carcinog 2007; 46:225 - 30; http://dx.doi.org/10.1002/mc.20270; PMID: 17219425
   PubMed Web of Science ®Google Scholar
• Wolf K, Wu YI, Liu Y, Geiger J, Tam E, Overall C, et al. Multi-step pericellular proteolysis controls the transition from individual to collective cancer cell invasion. Nat Cell Biol 2007; 9:893 - 904; http://dx.doi.org/10.1038/ncb1616; PMID: 17618273
   PubMed Web of Science ®Google Scholar
• Bartolomé RA, Ferreiro S, Miquilena-Colina ME, Martínez-Prats L, Soto-Montenegro ML, García-Bernal D, et al. The chemokine receptor CXCR4 and the metalloproteinase MT1-MMP are mutually required during melanoma metastasis to lungs. Am J Pathol 2009; 174:602 - 12; http://dx.doi.org/10.2353/ajpath.2009.080636; PMID: 19147814
   PubMed Web of Science ®Google Scholar
• Sohail A, Sun Q, Zhao H, Bernardo MM, Cho JA, Fridman R. MT4-(MMP17) and MT6-MMP (MMP25), A unique set of membrane-anchored matrix metalloproteinases: properties and expression in cancer. Cancer Metastasis Rev 2008; 27:289 - 302; http://dx.doi.org/10.1007/s10555-008-9129-8; PMID: 18286233
   PubMed Web of Science ®Google Scholar
• Seiki MEA, Yana I. Roles of pericellular proteolysis by membrane type-1 matrix metalloproteinase in cancer invasion and angiogenesis. Cancer Sci 2003; 94:569 - 74; http://dx.doi.org/10.1111/j.1349-7006.2003.tb01484.x; PMID: 12841863
   PubMed Web of Science ®Google Scholar
• Al-Raawi DEA, Abu-El-Zahab H, El-Shinawi M, Mohamed MM. Membrane type-1 matrix metalloproteinase (MT1-MMP) correlates with the expression and activation of matrix metalloproteinase-2 (MMP-2) in inflammatory breast cancer. Int J Clin Exp Med 2011; 4:265 - 75; PMID: 22140598
   PubMed Web of Science ®Google Scholar
• Furuichi KEA, Hisada Y, Shimizu M, Okumura T, Kitagawa K, Yoshimoto K, et al. Matrix metalloproteinase-2 (MMP-2) and membrane-type 1 MMP (MT1-MMP) affect the remodeling of glomerulosclerosis in diabetic OLETF rats. Nephrol Dial Transplant 2011; 26:3124 - 31; http://dx.doi.org/10.1093/ndt/gfr125; PMID: 21414971
   PubMed Web of Science ®Google Scholar
• Kachgal SEA, Carrion B, Janson IA, Putnam AJ. Bone marrow stromal cells stimulate an angiogenic program that requires endothelial MT1-MMP. J Cell Physiol 2012; 227:3546 - 55; http://dx.doi.org/10.1002/jcp.24056; PMID: 22262018
   PubMed Web of Science ®Google Scholar
• Soubani O, Ali AS, Logna F, Ali S, Philip PA, Sarkar FH. Re-expression of miR-200 by novel approaches regulates the expression of PTEN and MT1-MMP in pancreatic cancer. Carcinogenesis 2012; 33:1563 - 71; http://dx.doi.org/10.1093/carcin/bgs189; PMID: 22637745
   PubMed Web of Science ®Google Scholar
• Dangi-Garimella S, Strouch MJ, Grippo PJ, Bentrem DJ, Munshi HG. Collagen regulation of let-7 in pancreatic cancer involves TGF-β1-mediated membrane type 1-matrix metalloproteinase expression. Oncogene 2011; 30:1002 - 8; http://dx.doi.org/10.1038/onc.2010.485; PMID: 21057545
   PubMed Web of Science ®Google Scholar
• Ali S, Banerjee S, Logna F, Bao B, Philip PA, Korc M, et al. Inactivation of Ink4a/Arf leads to deregulated expression of miRNAs in K-Ras transgenic mouse model of pancreatic cancer. J Cell Physiol 2012; 227:3373 - 80; http://dx.doi.org/10.1002/jcp.24036; PMID: 22213426
   PubMed Web of Science ®Google Scholar
• Dong QEA, Yu D, Yang CM, Jiang B, Zhang H. Expression of the reversion-inducing cysteine-rich protein with Kazal motifs and matrix metalloproteinase-14 in neuroblastoma and the role in tumour metastasis. Int J Exp Pathol 2010; 91:368 - 73; http://dx.doi.org/10.1111/j.1365-2613.2010.00724.x; PMID: 20579139
   PubMed Web of Science ®Google Scholar
• Sun L, Yan W, Wang Y, Sun G, Luo H, Zhang J, et al. MicroRNA-10b induces glioma cell invasion by modulating MMP-14 and uPAR expression via HOXD10. Brain Res 2011; 1389:9 - 18; http://dx.doi.org/10.1016/j.brainres.2011.03.013; PMID: 21419107
   PubMed Web of Science ®Google Scholar
• Zhang H, Qi M, Li S, Qi T, Mei H, Huang K, et al. microRNA-9 targets matrix metalloproteinase 14 to inhibit invasion, metastasis, and angiogenesis of neuroblastoma cells. Mol Cancer Ther 2012; 11:1454 - 66; http://dx.doi.org/10.1158/1535-7163.MCT-12-0001; PMID: 22564723
   PubMed Web of Science ®Google Scholar
• Arai I, Nagano H, Kondo M, Yamamoto H, Hiraoka N, Sugita Y, et al. Overexpression of MT3-MMP in hepatocellular carcinoma correlates with capsular invasion. Hepatogastroenterology 2007; 54:167 - 71; PMID: 17419254
   PubMed Web of Science ®Google Scholar
• Lowy AM, Clements WM, Bishop J, Kong L, Bonney T, Sisco K, et al. beta-Catenin/Wnt signaling regulates expression of the membrane type 3 matrix metalloproteinase in gastric cancer. Cancer Res 2006; 66:4734 - 41; http://dx.doi.org/10.1158/0008-5472.CAN-05-4268; PMID: 16651426
   PubMed Web of Science ®Google Scholar
• Astarci E, Erson-Bensan AE, Banerjee S. Matrix metalloprotease 16 expression is downregulated by microRNA-146a in spontaneously differentiating Caco-2 cells. Dev Growth Differ 2012; 54:216 - 26; http://dx.doi.org/10.1111/j.1440-169X.2011.01324.x; PMID: 22348245
   PubMed Web of Science ®Google Scholar
• Xia H, Qi Y, Ng SS, Chen X, Li D, Chen S, et al. microRNA-146b inhibits glioma cell migration and invasion by targeting MMPs. Brain Res 2009; 1269:158 - 65; http://dx.doi.org/10.1016/j.brainres.2009.02.037; PMID: 19265686
   PubMed Web of Science ®Google Scholar
• Belguise KEA, Kersual N, Galtier F, Chalbos D. FRA-1 expression level regulates proliferation and invasiveness of breast cancer cells. Oncogene 2005; 24:1434 - 44; http://dx.doi.org/10.1038/sj.onc.1208312; PMID: 15608675
   PubMed Web of Science ®Google Scholar
• Xu B, Wang N, Wang X, Tong N, Shao N, Tao J, et al. MiR-146a suppresses tumor growth and progression by targeting EGFR pathway and in a p-ERK-dependent manner in castration-resistant prostate cancer. Prostate 2012; 72:1171 - 8; http://dx.doi.org/10.1002/pros.22466; PMID: 22161865
   PubMed Web of Science ®Google Scholar
• Collette T, Bellehumeur C, Kats R, Maheux R, Mailloux J, Villeneuve M, et al. Evidence for an increased release of proteolytic activity by the ectopic endometrial tissue in women with endometriosis and for involvement of matrix metalloproteinase-9. Hum Reprod 2004; 6:1257 - 64; http://dx.doi.org/10.1093/humrep/deh290
   Web of Science ®Google Scholar
• Folgueras AR, Pendás AM, Sánchez LM, López-Otín C. Matrix metalloproteinases in cancer: from new functions to improved inhibition strategies. Int J Dev Biol 2004; 48:411 - 24; http://dx.doi.org/10.1387/ijdb.041811af; PMID: 15349816
   PubMed Web of Science ®Google Scholar
• Qi JH, Ebrahem Q, Moore N, Murphy G, Claesson-Welsh L, Bond M, et al. A novel function for tissue inhibitor of metalloproteinases-3 (TIMP3): inhibition of angiogenesis by blockage of VEGF binding to VEGF receptor-2. Nat Med 2003; 9:407 - 15; http://dx.doi.org/10.1038/nm846; PMID: 12652295
   PubMed Web of Science ®Google Scholar
• Brew K, Nagase H. The tissue inhibitors of metalloproteinases (TIMPs): an ancient family with structural and functional diversity. Biochim Biophys Acta 2010; 1803:55 - 71; http://dx.doi.org/10.1016/j.bbamcr.2010.01.003; PMID: 20080133
   PubMed Web of Science ®Google Scholar
• Yu D, Zhou H, Xun Q, Xu X, Ling J, Hu Y. microRNA-103 regulates the growth and invasion of endometrial cancer cells through the downregulation of tissue inhibitor of metalloproteinase 3. Oncol Lett 2012; 3:1221 - 6; PMID: 22783422
   PubMed Web of Science ®Google Scholar
• Wang B, Hsu SH, Majumder S, Kutay H, Huang W, Jacob ST, et al. TGFbeta-mediated upregulation of hepatic miR-181b promotes hepatocarcinogenesis by targeting TIMP3. Oncogene 2010; 29:1787 - 97; http://dx.doi.org/10.1038/onc.2009.468; PMID: 20023698
   PubMed Web of Science ®Google Scholar
• He Y, Cui Y, Wang W, Gu J, Guo S, Ma K, et al. Hypomethylation of the hsa-miR-191 locus causes high expression of hsa-mir-191 and promotes the epithelial-to-mesenchymal transition in hepatocellular carcinoma. Neoplasia 2011; 13:841 - 53; PMID: 21969817
   PubMed Web of Science ®Google Scholar
• Almog N, Ma L, Schwager C, Brinkmann BG, Beheshti A, Vajkoczy P, et al. Consensus micro RNAs governing the switch of dormant tumors to the fast-growing angiogenic phenotype. PLoS One 2012; 7:e44001; http://dx.doi.org/10.1371/journal.pone.0044001; PMID: 22952847
   PubMedGoogle Scholar
• Garofalo M, Di Leva G, Romano G, Nuovo G, Suh SS, Ngankeu A, et al. miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulation. Cancer Cell 2009; 16:498 - 509; http://dx.doi.org/10.1016/j.ccr.2009.10.014; PMID: 19962668
   PubMed Web of Science ®Google Scholar
• Gabriely G, Wurdinger T, Kesari S, Esau CC, Burchard J, Linsley PS, et al. MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators. Mol Cell Biol 2008; 28:5369 - 80; http://dx.doi.org/10.1128/MCB.00479-08; PMID: 18591254
   PubMed Web of Science ®Google Scholar
• Oh J, Takahashi R, Kondo S, Mizoguchi A, Adachi E, Sasahara RM, et al. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 2001; 107:789 - 800; http://dx.doi.org/10.1016/S0092-8674(01)00597-9; PMID: 11747814
   PubMed Web of Science ®Google Scholar
• Clark JC, Thomas DM, Choong PF, Dass CR. RECK--a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer. Cancer Metastasis Rev 2007; 26:675 - 83; http://dx.doi.org/10.1007/s10555-007-9093-8; PMID: 17828469
   PubMed Web of Science ®Google Scholar
• Zhang Z, Li Z, Gao C, Chen P, Chen J, Liu W, et al. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest 2008; 88:1358 - 66; http://dx.doi.org/10.1038/labinvest.2008.94; PMID: 18794849
   PubMed Web of Science ®Google Scholar
• Reis ST, Pontes-Junior J, Antunes AA, Dall’Oglio MF, Dip N, Passerotti CC, et al. miR-21 may acts as an oncomir by targeting RECK, a matrix metalloproteinase regulator, in prostate cancer. BMC Urol 2012; 12:14; http://dx.doi.org/10.1186/1471-2490-12-14; PMID: 22642976
   PubMed Web of Science ®Google Scholar
• Zhu Y, Yu X, Fu H, Wang H, Wang P, Zheng X, et al. MicroRNA-21 is involved in ionizing radiation-promoted liver carcinogenesis. Int J Clin Exp Med 2010; 3:211 - 22; PMID: 20827319
   PubMed Web of Science ®Google Scholar
• Liu C, Yu J, Yu S, Lavker RM, Cai L, Liu W, et al. MicroRNA-21 acts as an oncomir through multiple targets in human hepatocellular carcinoma. J Hepatol 2010; 53:98 - 107; http://dx.doi.org/10.1016/j.jhep.2010.02.021; PMID: 20447717
   PubMed Web of Science ®Google Scholar
• Han L, Yue X, Zhou X, Lan FM, You G, Zhang W, et al. MicroRNA-21 expression is regulated by β-catenin/STAT3 pathway and promotes glioma cell invasion by direct targeting RECK. CNS Neurosci Ther 2012; 18:573 - 83; http://dx.doi.org/10.1111/j.1755-5949.2012.00344.x; PMID: 22630347
   PubMed Web of Science ®Google Scholar
• Ziyan W, Shuhua Y, Xiufang W, Xiaoyun L. MicroRNA-21 is involved in osteosarcoma cell invasion and migration. Med Oncol 2011; 28:1469 - 74; http://dx.doi.org/10.1007/s12032-010-9563-7; PMID: 20480266
   PubMed Web of Science ®Google Scholar
• Park JK, Lee EJ, Esau C, Schmittgen TD. Antisense inhibition of microRNA-21 or -221 arrests cell cycle, induces apoptosis, and sensitizes the effects of gemcitabine in pancreatic adenocarcinoma. Pancreas 2009; 38:e190 - 9; http://dx.doi.org/10.1097/MPA.0b013e3181ba82e1; PMID: 19730150
   PubMed Web of Science ®Google Scholar
• Jung HM, Phillips BL, Patel RS, Cohen DM, Jakymiw A, Kong WW, et al. Keratinization-associated miR-7 and miR-21 regulate tumor suppressor reversion-inducing cysteine-rich protein with kazal motifs (RECK) in oral cancer. J Biol Chem 2012; 287:29261 - 72; http://dx.doi.org/10.1074/jbc.M112.366518; PMID: 22761427
   PubMed Web of Science ®Google Scholar
• Loayza-Puch F, Yoshida Y, Matsuzaki T, Takahashi C, Kitayama H, Noda M. Hypoxia and RAS-signaling pathways converge on, and cooperatively downregulate, the RECK tumor-suppressor protein through microRNAs. Oncogene 2010; 29:2638 - 48; http://dx.doi.org/10.1038/onc.2010.23; PMID: 20154725
   PubMed Web of Science ®Google Scholar
• Li N, Tang B, Zhu ED, Li BS, Zhuang Y, Yu S, et al. Increased miR-222 in H. pylori-associated gastric cancer correlated with tumor progression by promoting cancer cell proliferation and targeting RECK. FEBS Lett 2012; 586:722 - 8; http://dx.doi.org/10.1016/j.febslet.2012.01.025; PMID: 22321642
   PubMed Web of Science ®Google Scholar
• Bauvois B. New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor progression. Biochim Biophys Acta 2012; 1825:29 - 36; PMID: 22020293
   PubMed Web of Science ®Google Scholar
• Wang H, Wu J, Meng X, Ying X, Zuo Y, Liu R, et al. MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. Carcinogenesis 2011; 32:1033 - 42; http://dx.doi.org/10.1093/carcin/bgr081; PMID: 21565830
   PubMed Web of Science ®Google Scholar